Category: Courts/First Amendment

FDA Plans for Off-label Communication Draft Guidance, Meeting

PhRMA Authors Call for FDA to Establish Off-label Communication Safe Harbor

In Amicus Brief, PhRMA Says Off-label Case “Raises Serious First Amendment Concerns”

FDA Plans to Study Effect of DTC Ads on Adolescents

Kamp to Washington Post: Companies Should Be Able to Speak Truthfully About Drugs

New FDA Social Media Guidances Address Space-limited Media, Correcting Online Misinformation

New Yorker Article Weighs Sales Rep Free Speech Arguments in Off-label Context

CHC Comment to FDA: Less Is More in DTC TV Ads

FDA Willing to “Re-examine” Off-label Policies in Light of First Amendment Rulings